Neuronetics
Signal active
Organization
Contact Information
Overview
Neuronetics is a medical technology company. They develop non-invasive therapies for psychiatric and neurological disorders using mri-strength magnetic field pulses. They specialize in providing therapy for mental health.
About
Industries
Biotechnology, Health Care, Manufacturing, Medical Device, Therapeutics
Founded
2003
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Neuronetics headquartered in United States, North America, operates in the Biotechnology, Health Care, Manufacturing, Medical Device, Therapeutics sector. The company focuses on Biotechnology and has secured $89.6B in funding across 240 round(s). With a team of 101-250 employees, Neuronetics is actively contributing to advancements in Biotechnology. Their latest funding round, Series D - Neuronetics, raised $30.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
12
Investors
8
Lead Investors
0
Total Funding Amount
$373.4M
Details
7
Neuronetics has raised a total of $373.4M in funding over 7 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2006 | Late Stage Venture | 35.0M | ||
| 2015 | Late Stage Venture | 34.3M | ||
| 2011 | Late Stage Venture | 30.0M | ||
| 2009 | Late Stage Venture | 30.0M |
Investors
Neuronetics is funded by 61 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Quaker BioVentures | - | FUNDING ROUND - Quaker BioVentures | 34.3M |
| Investor Growth Capital Limited | - | FUNDING ROUND - Investor Growth Capital Limited | 34.3M |
| Neuronetics | - | FUNDING ROUND - Neuronetics | 34.3M |
| Partisan Management Group | - | FUNDING ROUND - Partisan Management Group | 34.3M |
Recent Activity
There is no recent news or activity for this profile.